These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23028957)

  • 21. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
    Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
    Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A non-characteristic response of L1210 cells to lovastatin.
    Engelke KJ; Hacker MP
    Biochem Biophys Res Commun; 1994 Aug; 203(1):400-7. PubMed ID: 8074684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of inhibitors of isoprenylation in proliferation, phenotype and apoptosis of human retinal pigment epithelium.
    Capeáns C; Piñeiro A; Pardo M; Carneiro C; Blanco MJ; Viñuela JM; Sánchez Salorio M; Domínguez F
    Graefes Arch Clin Exp Ophthalmol; 2001 Mar; 239(3):188-98. PubMed ID: 11405068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salidroside, a Chemopreventive Glycoside, Diminishes Cytotoxic Effect of Cisplatin in Vitro.
    Zduriencikova M; Cholujova D; Duraj J; Mastihubova M; Mastihuba V; Karnisova Potocka E; Galova E; Sevcovicova A; Klapakova M; Horvathova E
    Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):346-354. PubMed ID: 28889522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.
    Naderi S; Blomhoff R; Myklebust J; Smeland EB; Erikstein B; Norum KR; Blomhoff HK
    Exp Cell Res; 1999 Oct; 252(1):144-53. PubMed ID: 10502407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthocyanins Isolated from
    Paramanantham A; Kim MJ; Jung EJ; Kim HJ; Chang SH; Jung JM; Hong SC; Shin SC; Kim GS; Lee WS
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA methyltransferase modulates cisplatin-induced DNA double-strand breaks by targeting the homologous recombination pathway in nasopharyngeal carcinoma.
    Chen SH; Huang WT; Kao WC; Hsiao SY; Pan HY; Fang CW; Shiue YL; Chou CL; Li CF
    J Biomed Sci; 2021 Jan; 28(1):2. PubMed ID: 33397362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy.
    Zhang N; Dai L; Qi Y; Di W; Xia P
    Int J Oncol; 2013 Jun; 42(6):2053-9. PubMed ID: 23592281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
    Keyomarsi K; Sandoval L; Band V; Pardee AB
    Cancer Res; 1991 Jul; 51(13):3602-9. PubMed ID: 1711413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
    Hamadmad SN; Hohl RJ
    Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 33. Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.
    Piro G; Roca MS; Bruzzese F; Carbone C; Iannelli F; Leone A; Volpe MG; Budillon A; Di Gennaro E
    Mol Cancer Ther; 2019 Aug; 18(8):1405-1417. PubMed ID: 31189612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitizing thermochemotherapy with a PARP1-inhibitor.
    Oei AL; Vriend LE; van Leeuwen CM; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJ; Crezee J; Kanaar R; Kok HP; Krawczyk PM; Franken NA
    Oncotarget; 2017 Mar; 8(10):16303-16312. PubMed ID: 27557507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of cisplatin on cell cycle regulators].
    Nishio K; Saijo N
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):289-94. PubMed ID: 8109984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
    Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
    Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of cisplatin cytotoxicity by 9-aminocamptothecin.
    Goldwasser F; Valenti M; Torres R; Kohn KW; Pommier Y
    Clin Cancer Res; 1996 Apr; 2(4):687-93. PubMed ID: 9816219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.